Computational Biology Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	160 Pages	Coherent Market Insights	July, 2023	CMI18107843

Best Price Guarantee
Price	from $4,500
Length	160 Pages
Publisher	Coherent Market Insights
Published Date	July, 2023
SKU	CMI18107843

Computational Biology Market, By Type (Cellular and Biological Simulation (Computational Genomics, Computational Proteomics, Pharmacogenomics, and Others (Transcriptomics/Metabolomic)), Disease Modeling and Simulation Applications (Drug Discovery, Drug Development)), By Tools (Content/Database, Analysis Software and Services, and IT Infrastructure (Hardware)),and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Computational biology aims to advance healthcare by developing computational models of diseases, personalizing these models using data from patients, and applying these models to improve the diagnosis and treatment of diseases. These patient models are used to discover novel risk biomarkers, predict disease progression, design optimal treatments, and identify new drug targets for applications such as cancer, cardiovascular disease, and neurological disorders. The development and application of patient-specific, quantitative models can be used to understand, diagnose, and treat disease. Computational medicines can be used for molecular, physiological, and anatomical medicines. The integration of biomedical signal processing, computational modeling, machine learning, and health informatics can be done to develop new approaches in personalized medicine via electronic health records, physiological time series data, and genomics.

Market Dynamics

The increasing launch of new products, mergers, and acquisitions by key market players is expected to drive the global computational biology market growth. For instance, on July 25, 2022, Replay, a U.S.-based genome writing company, received US$ 55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay’s genomic medicine toolkit encompasses a portfolio of disruptive platform technologies to write and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell therapy platform, and a proprietary genome writing platform. The Replay, a U.S.-based genome writing company solves challenges in currently limiting clinical progress including increased payload capacity, off the shelf cell therapies that can reduce the cost of goods, improve production speed, volume and consistency, and expand the potential for genome engineering.

Key features of the study:

This report provides an in-depth analysis of the global computational biology market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global computational biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global computational biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global computational biology market

Detailed Segmentation:

Global Computational Biology Market, By Type:
Cellular and Biological Simulation
Computational Genomics
Computational Proteomics
Pharmacogenomics
Others (Transcriptomics/Metabolomic)
Disease Modeling and Simulation Applications
Drug Discovery
Drug Development
Global Computational Biology Market, By Tools:
Content/Database
Analysis Software and Services
IT Infrastructure (Hardware)
Global Computational Biology Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
North Africa
Central Africa
South Africa
Company Profiles
Accelrys
Certara, L.P.
Chemical Computing Group Inc.
Compugen, ltd.
Entelos, Inc. (Rosa & Co. LLC)
Genedata AG
Insilico Biotechnology AG
Leadscope, Inc.
Nimbus Discovery LLC
Rhenovia Pharma SAS
Schrodinger
Simulation Plus, Inc.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Type; Market Snapshot, By Tools; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Market Opportunities; Impact Analysis; Recent Product Launches; Epidemiology; Merger, Acquisition, and Collaborations; Regulatory Scenario; Key Developments; PEST Analysis
4. Global Computational Biology Market - COVID-19 Impact Analysis: Economic Impact; COVID-19 Epidemiology; Impact on Supply and Demand
5. Global Computational Biology Market, By Type, 2018-2030, (US$ Billion): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018-2030; Segment Trends; Cellular and Biological Simulation; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion); Computational Genomics; Computational Proteomics; Pharmacogenomics; Others (Transcriptomics/Metabolomic); Disease Modeling and Simulation Applications; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion); Drug Discovery; Drug Development
6. Global Computational Biology Market, By Tools, 2018-2030, (US$ Billion): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018-2030; Segment Trends; Content/Database; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion); Analysis Software and Services; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion); IT Infrastructure (Hardware); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2018–2030, (US$ Billion)
7. Global Computational Biology Market, By Region, 2018-2030, (US$ Billion): Introduction; Market Share Analysis, By Region, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Region, 2018-2030; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Tools, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Tools, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Tools, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion); U.K.; Germany; Italy; France; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Tools, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion); China; India; Japan; ASEAN; Australia; South Korea; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Tools, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By type, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Tools, 2018 - 2030, (US$ Billion); Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Billion); North Africa; Central Africa; South Africa
8. Competitive Landscape: Accelrys; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Certara, L.P.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Chemical Computing Group Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Compugen, ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Entelos, Inc. (Rosa and Co. LLC); Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Genedata AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Insilico Biotechnology AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Leadscope, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Nimbus Discovery LLC; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Rhenovia Pharma SAS; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Schrodinger; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies; Simulation Plus, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Market Strategies
9. Section: Research Methodology; About Us; *Browse 28 market data tables and 25 figures on “Computational Biology Market” - Global forecast to 2030